Credit Suisse Ag Reata Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $87,221 - $116,012	1,101 Added 2.65%	42,577 $4.34 Million
Q1 2023 May 10, 2023	BUY	$30.85 - $93.17 $72,003 - $217,458	2,334 Added 5.96%	41,476 $3.77 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $209,361 - $398,023	9,452 Added 31.84%	39,142 $1.49 Million
Q3 2022 Nov 10, 2022	BUY	$19.41 - $36.49 $3,066 - $5,765	158 Added 0.54%	29,690 $747,000
Q2 2022 Aug 12, 2022	BUY	$20.71 - $36.5 $29,138 - $51,355	1,407 Added 5.0%	29,532 $898,000
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $28,099 - $46,134	1,165 Added 4.32%	28,125 $921,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $19,591 - $84,884	-765 Reduced 2.76%	26,960 $711,000
Q3 2021 Nov 12, 2021	BUY	$100.0 - $143.02 $202,600 - $289,758	2,026 Added 7.88%	27,725 $2.79 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $55,180 - $106,659	705 Added 2.82%	25,699 $3.64 Million
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $406,688 - $573,075	4,315 Added 20.87%	24,994 $2.49 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $107,743 - $194,958	1,056 Added 5.38%	20,679 $2.56 Million
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $33,203 - $57,985	355 Added 1.84%	19,623 $1.91 Million
Q2 2020 Aug 12, 2020	SELL	$126.3 - $176.56 $1.23 Million - $1.72 Million	-9,741 Reduced 33.58%	19,268 $3.01 Million
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $1.69 Million - $3.37 Million	-13,603 Reduced 31.92%	29,009 $4.19 Million
Q4 2019 Feb 12, 2020	BUY	$74.57 - $217.92 $1.62 Million - $4.75 Million	21,776 Added 104.51%	42,612 $8.71 Million
Q3 2019 Nov 12, 2019	BUY	$71.26 - $95.75 $444,163 - $596,809	6,233 Added 42.68%	20,836 $1.67 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $1.08 Million - $1.31 Million	-13,922 Reduced 48.81%	14,603 $1.38 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $280,779 - $550,683	5,410 Added 23.4%	28,525 $2.44 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $76.44 $75,529 - $118,405	1,549 Added 7.18%	23,115 $1.3 Million
Q3 2018 Nov 13, 2018	SELL	$35.64 - $92.06 $52,961 - $136,801	-1,486 Reduced 6.45%	21,566 $1.76 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $93,877 - $192,839	4,708 Added 25.67%	23,052 $806,000
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $12,120 - $18,295	606 Added 3.42%	18,344 $376,000
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $194,479 - $288,983	8,686 Added 95.96%	17,738 $502,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $237,977 - $288,577	9,052	9,052 $282,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account